Oxidative stress and inflammatory markers are associated with depression and nicotine dependence

Neuroscience Letters

Volumn 544, Issue , 2013, Pages 136-140

  Vargas, Heber Odebrecht ^a,b   Nunes, Sandra Odebrecht Vargas ^a,b   de Castro, Márcia Regina Pizzo ^b   Vargas, Mateus Mendonça ^b   Barbosa, Décio Sabbatini ^a   Bortolasci, Chiara Cristina ^b   Venugopal, Kamalesh ^d   Dodd, Seetal ^c,d,f   Berk, Michael ^c,d,e,f,g  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b Center of Approach and Treatment for Smokers   (Brazil)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d DEAKIN UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f BARWON HEALTH   (Australia)

^g FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Depression; Inflammation; Nicotine dependence; Oxidative stress

Indexed keywords

ALCOHOL; C REACTIVE PROTEIN; FIBRINOGEN; LIPID HYDROPEROXIDE; MALONALDEHYDE; NICOTINE; NITRIC OXIDE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; DISEASE MARKER; DSM-IV; FEMALE; HAMILTON SCALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SMOKING; SUICIDE ATTEMPT; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BIOLOGICAL MARKERS; BRAZIL; COMORBIDITY; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS; SEX DISTRIBUTION; SICK LEAVE; SUICIDE, ATTEMPTED; SURVIVAL ANALYSIS; SURVIVAL RATE; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84878380658     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.03.059     Document Type: Article

References (33)

1. Barsotti A., Fabbi P., Fedele M., Garibaldi S., Balbi M., Bezante G.P., Risso D., Indiveri F., Ghigliotti G., Brunelli C. Role of advanced oxidation protein products and Thiol ratio in patients with acute coronary syndromes. Clin. Biochem. 2011, 44(8-9):605-611.
2. Berk M., Kapczinski F., Andreazza A.C., Dean O.M., Giorlando F., Maes M., Yucel M., Gama C.S., Dodd S., Dean B., Magalhães P.V.S., Amminger P., McGorry P., Malhi G.S. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 2011, 35:804-817.
3. Breslau N., Novak S.P., Kessler R.C. Psychiatric disorders and stages of smoking. Biol. Psychiatry 2004, 55:69-76.
4. Breslau N., Schultz L., Johnson E., Peterson E., Davis G. Smoking and the risk of suicidal behavior: a prospective study of a community sample. Arch. Gen. Psychiatry 2005, 62(3):328-334.
5. Buico A., Cassino C., Ravera M., Betta P.-G., Osella D. Oxidative stress in total antioxidant capacity in human plasma. Redox Rep. 2009, 14(3):125-131.
6. Castro M.R.P., Matsuo T., Nunes S.O.V. Clinical characteristics and quality of life of smokers at a referral center for smoking cessation. J. Bras. Pneumol. 2010, 36(1):67-74.
7. Castro M.R.P., Matsuo T., Nunes S.O.V. Characteristics of smokers in smoking cessation interventions: an analysis of sex differences. Addict. Disord. Their Treat. 2010, 9(4):135-142.
8. Del Ben C.M., Vilela J.A.A., Crippa J.A.S., Hallak J.E.C., Labate C.M., Zuardi A.W. Confiabilidade da "Entrevista Clínica Estruturada para o D.S.M.-IV" - versão clínica traduzida para o português. Rev. Bras. Psiquiatr. 2001, 23(3):156-159.
9. Elovainio M., Aalto A.-M., Kivimäki M., Pirkola S., Sundvall J., Lönnqvist J., Reunanen A. Depression and C-reactive protein: population-based Health 2000 Study. Psychosom. Med. 2009, 71:423-430.
10. Forlenza M.J., Miller G.E. Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression. Psychosom. Med. 2006, 68(1):1-7.
11. Grimes D., Schultz K.F. An overview of clinical research the lay of the land. Lancet 2002, 359:57-61.
12. Hamer M., Molloy G.J., de Oliveira C., Demakakos P. Persistent depressive symptomatology and inflammation: to what extent do health behaviours and weight control mediate this relationship?. Brain Behav. Immun. 2009, 23:413-418.
13. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 2006, 97:1634-1658.
14. Jamal M., Willem Van der Does A.J., Cuijpers P., Penninx B.W.J.H. Association of smoking and nicotine dependence with severity and course of symptoms in patients with depressive or anxiety disorder. Drug Alcohol Depend. 2012, 126(1-2):138-146.
15. Jentzch A.M., Bachman H., Furst P., Biesalski H.K. Improved analysis of malondialdehyde in human body fluids. Free Radic. Biol. Med. 1996, 20:251-256.
16. 2+ in the presence of xylenol orange. Comparison with the TBA assay and an Iodometric method. Lipids 1991, 26(10):356-358.
17. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev. 2012, 36(12):764-785.
18. Liukkonen T., Silvennoinen-Kassinen S., Jokelainen J., Räsänen P., Leinonen M., Meyer-Rochow V.B., Timonen M. The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study. Biol. Psychiatry 2006, 60:825-830.
19. Maes M., Chang Y.S., Galecki P., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:676-692.
20. Malone K.M., Waternaux C., Haas G.L., Cooper T.B., Li S., Mann J.J. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. Am. J. Psychiatry 2003, 160:773-779.
21. Moreno R.A., Moreno D.H. Hamilton and Montgomery & Ǻsberg depression rating scales. Rev. Psiquiatr. Clin. 1998, 25:262-272.
22. Moylan S., Maes M., Wray N.R., Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry 2012, 33. 10.1038/mp.2012.
23. Navarro-Gonzálvez J.A., García-Benayas C., Arenas J. Semiautomated measurement of nitrate in biological fluids. Clin. Chem. 1998, 44:679-681.
24. Nunes S.O.V., Vargas H.O., Brum J., Prado E., Vargas M.M., de Castro M.R.P., Dodd S., Berk M. A comparison of inflammatory markers in depressed and nondepressed smokers. Nicotine Tob. Res. 2012, 14:540-546.
25. Pasco J.A., Williams L.J., Jacka F.N., Ng F., Henry M.J., Nicholson G.C., Kotowicz M.A., Berk M. Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br. J. Psychiatry 2008, 193:322-326.
26. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
27. Repetto M., Reides C., Carretero M.L.G., Costa M., Griemberg G., Llesuy S. Oxidative stress in blood of HIV infected patients. Clin. Chim. Acta 1996, 255:107-117.
28. Rytilä P., Rehn T., Ilumets H., Rouhos A., Sovijärvi A., Myllärniemi M., Kinnula V.L. Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD. Respir. Res. 2006, 7:69.
29. Talarowska M., Gałecki P., Maes M., Orzechowska A., Chamielec M., Bartosz G., Kowalczyk E. Nitric oxide plasma concentration associated with cognitive impairment inpatients with recurrent depressive disorder. Neurosci. Lett. 2012, 510:127-131.
30. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., Jungers P., Deschamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 4:1304-1313.
31. World Health Organization (WHO) The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction 2002, 97(9):1183-1194.
32. World Health Organization (WHO). WHO report on the global tobacco epidemic, 2008: the MPOWER package. Geneva: World Health Organization; 2008.
33. Yager S., Forlenza M.J., Miller G.E. Depression and oxidative damage to lipids. Psychoneuroendocrinology 2010, 35:1356-1362.